377

PROSPECTIVE EVALUATION OF PROVIDER COMPLIANCE WITH RISK-STRATIFIED PANCREATECTOMY CLINICAL PATHWAYS

Date
May 19, 2024

Background: Risk-stratified pancreatectomy clinical pathways (RSPCP) are associated with reduced length of stay (LOS) and major complications. Imperfect provider compliance is expected as RSPCP are guidelines for patient expectations, provider order standardization, and trainee education; however, the association of pathway adherence to postoperative outcomes has never been examined prospectively and remains uncertain. Within this context, this prospective quality improvement study evaluated provider compliance with discrete pathway components and the association of compliance with postoperative outcomes. Methods: Compliance with published RSPCP components, including postoperative day (POD)1-3 diet advancement, reduced intravenous (IV) fluids, POD1 nasogastric tube (NGT) and POD1-3 drain removal, POD1-2 transition to oral medications, and immediate venous thromboembolic prophylaxis, was prospectively recorded from 4/2022-7/2023. Reasons for pathway deviation were categorized and recorded at the time of occurrence and evaluated for associations with index LOS and 90-day outcomes. Results: Of 221 total cases, 82 were distal pancreatectomies (DP) with median LOS 4 days (IQR2-6), 83 were low-risk pancreatoduodenectomies (LR-PD) with median LOS 4 days (IQR2-6), and 56 were high-risk PD (HR-PD) with median LOS 5 days (IQR2-8). Pathway compliance was 100% for only 42 patients (19%). The median number of per-patient deviations increased with complexity of operation (DP 2 deviations, IQR1-5; LR-PD 3 deviations, IQR1-4; HR-PD 3.5 deviations, IQR2-5; P=0.021) (Figure 1). The most common deviations were IV fluids beyond POD2 (46%) and delayed transition to oral medications (45%). Patients with ≥1 pathway deviation (delays in advancement of care) had a significantly longer LOS (5days [IQR4-6] vs 4days [IQR3-4], P<0.001) and a higher rate of ACCORDION grade ≥3 complications (31% vs 7%, P<0.001) (Figure 2), but no reduction in readmission rate, delayed gastric emptying (DGE), or grade B/C fistula. Most common reasons for pathway deviation were delayed return of bowel function (31%), additional interventional drains (23%), and provider preference (23%). By multiple linear regression, initiation of a clear liquid diet by POD1 (after required 8am NGT removal) was associated with a shorter LOS (coefficient 3.361, P=0.018). Conclusions: Pathway deviations are more common in high-risk PD and are associated with longer LOS and more major complications. While most pathway non-compliance is driven by patient condition, provider preference still affects almost one-fourth of patients, with delays in advancement not reducing DGE, B/C fistulas, or readmissions. While perfect RSPCP compliance is not a realistic goal, improved standardization and engagement of all clinical stakeholders in pathway revision and implementation are critical to iteratively improve patient outcomes.
<b>Figure 1</b>: Number of pathway deviations stratified by RSPCP.

Figure 1: Number of pathway deviations stratified by RSPCP.

<b>Figure 2</b>: Number of pathway deviations in patients with and without ACCORDION grade ≥3 complications.

Figure 2: Number of pathway deviations in patients with and without ACCORDION grade ≥3 complications.

Presenter

Speakers

Speaker Image for Elsa Arvide
The University of Texas MD Anderson Cancer Center
Speaker Image for Michael Kim
U.T. MD Anderson Cancer Center
Speaker Image for Naruhiko Ikoma
Univ. Texas MD Anderson Cancer Center
Speaker Image for Rebecca Snyder
Brody School of Medicine at ECU
Speaker Image for Jessica Maxwell
The University of Texas MD Anderson Cancer Center

Tracks

Related Products

Thumbnail for VALIDATION AND RECALIBRATION OF RISK-STRATIFIED PANCREATODUODENECTOMY DRAIN FLUID AMYLASE REMOVAL CRITERIA
VALIDATION AND RECALIBRATION OF RISK-STRATIFIED PANCREATODUODENECTOMY DRAIN FLUID AMYLASE REMOVAL CRITERIA
LUNCH AND TRAINEE JEOPARDY! 12:00 PM - 1:00 PM LEADERSHIP FORUM, NETWORKING SESSION AND ROUNDTABLES 4:00 PM - 5:30 PM KEYNOTE ADDRESS: FUTURE SCENARIO PLANNING TO PREDICT THE FUTURE OF SURGERY 4:00 PM - 4:30 PM
Thumbnail for USE OF AIR LEAK TEST TO REDUCE BILE LEAKS AND ORGAN SPACE INFECTIONS: A STEP TOWARDS MORE DRAIN-FREE HEPATECTOMY PATIENTS
USE OF AIR LEAK TEST TO REDUCE BILE LEAKS AND ORGAN SPACE INFECTIONS: A STEP TOWARDS MORE DRAIN-FREE HEPATECTOMY PATIENTS
Introduction: Though still common practice, the indications for surgical drain placement following hepatectomy have been put into question…
Thumbnail for PROSPECTIVE COHORT STUDY OF COMPLIANCE WITH RISK-STRATIFIED POST-HEPATECTOMY PATHWAYS
PROSPECTIVE COHORT STUDY OF COMPLIANCE WITH RISK-STRATIFIED POST-HEPATECTOMY PATHWAYS
LUNCH AND TRAINEE JEOPARDY! 12:00 PM - 1:00 PM LEADERSHIP FORUM, NETWORKING SESSION AND ROUNDTABLES 4:00 PM - 5:30 PM KEYNOTE ADDRESS: FUTURE SCENARIO PLANNING TO PREDICT THE FUTURE OF SURGERY 4:00 PM - 4:30 PM
Thumbnail for CLASSIFICATION OF POST-PANCREATECTOMY READMISSIONS WITH OPPORTUNITIES FOR TARGETED MITIGATION STRATEGIES
CLASSIFICATION OF POST-PANCREATECTOMY READMISSIONS WITH OPPORTUNITIES FOR TARGETED MITIGATION STRATEGIES
Pancreatic ductal adenocarcinoma (PDAC) exists in several morphological subtypes differing in prognostic significance. However, to date, a clinico-morphological correlation of these subtypes in the context of neoadjuvant therapy (NAT) has not been performed…